GlaxoSmithKline plc (GSK)

NYSE - NYSE Real Time Price. Currency in USD
43.13+0.23 (+0.54%)
At close: 4:02 PM EDT

42.91 -0.22 (-0.51%)
After hours: 5:16 PM EDT

People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close42.90
Bid42.93 x 200
Ask43.81 x 200
Day's Range42.82 - 43.27
52wk Range37.82 - 45.58
1y Target EstN/A
Market Cap102.67B
P/E Ratio (ttm)2,695.62
Avg Vol (3m)2,835,234
Dividend & Yield2.20 (5.05%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Associated Press2 hours ago

    Glaxo paying $20M to resolve SEC charges of China bribery

    WASHINGTON (AP) — GlaxoSmithKline PLC has agreed to pay $20 million to resolve U.S. regulators' allegations that the pharmaceutical giant's China operations bribed officials to boost drug sales.

  • The Wall Street Journal4 hours ago

    [$$] GlaxoSmithKline to Pay $20 Million to Settle SEC Bribery Probe

    GlaxoSmithKline PLC agreed to pay $20 million to settle charges that the drugmaker’s Chinese subsidiaries engaged in bribery schemes to increase sales in the Asian country, the Securities and Exchange ...

  • Reuters6 hours ago

    GlaxoSmithKline to pay $20 mln to settle U.S. foreign bribery case

    GlaxoSmithKline Plc will pay $20 million to settle civil charges that it masked bribes to foreign officials in China by disguising them as legitimate travel, entertainment and marketing expenses, U.S. regulators said on Friday. The pharmaceutical company agreed to settle the case with the Securities and Exchange Commission without admitting or denying any wrongdoing. In a statement, the company said it had cooperated with the SEC and it had received credit for taking steps to improve its operations, such as changing how sales representatives are paid and stopping the practice of paying healthcare professionals to speak to doctors about the company's products.